Generation and validation of a CRF1:Cre transgenic rat: The role of central amygdala CRF1 in nociception and anxiety-like behavior
Marcus M. WeeraiD, Abigail E. Agoglia, Eliza A. DouglassiD, Zhiying JiangiD, Shivakumar RajamanickamiD, Rosetta S. Shackett, Melissa A. HermaniD, Nicholas J. JusticeiD, Nicholas W. GilpiniD
Abstract
Corticotropin-releasing factor type-1 (CRF1) receptors are critical to stress responses because they allow neurons to respond to CRF released in response to stress. Our understanding of the precise role of CRF1-expressing neuronal populations in CRF-mediated behaviors has been largely limited to mouse experiments due to the lack of genetic tools available to selectively visualize and manipulate CRF1+ cells in rats. Here, we describe the generation and validation of a transgenic CRF1:Cre-tdTomato rat, which expresses a bicistronic iCre-2A-tdTomato transgene directed by 200kb of promoter and enhacer sequence surrounding the Crhr1 cDNA present within a BAC clone, that has been transgenically inserted into the rat genome. We report that Crhr1 and Cre mRNA expression are highly colocalized in CRF1:Cre-tdTomato rats within both the central amygdala (CeA), composed of mostly GABAergic neurons, and in the basolateral amygdala (BLA), composed of mostly glutamatergic neurons. In the CeA, membrane properties, inhibitory synaptic transmission, and responses to CRF bath application in tdTomato+ neurons are similar to those previously reported in GFP+ cells in CRFR1-GFP mice. We show that stimulatory DREADD receptors can be selectively targeted to CeA CRF1+ cells via virally delivered Cre-dependent transgenes, that transfected Cre/tdTomato+ cells are activated by clozapine-n-oxide in vitro and in vivo, and that activation of these cells in vivo increases anxiety-like behavior and nocifensive responses. Given the accuracy of expression in the CRF1:Cre rat, modern genetic techniques used to investigate the anatomy, physiology, and behavioral function of CRF1+ neurons and circuits can now be performed in assays that require the use of rats as the model organism. Impact StatementA novel transgenic rat for studying the role of specific corticotropin-releasing factor type-1 receptor-expressing cell populations in physiology and behavior.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 28
- FWCI
- 2.43
- Field percentile
- top 10%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting Corticotropin-Releasing Hormone Receptor Type 1 (CRHR1) Neurons: Validating the Specificity of a Novel Transgenic Crhr1-FlpO Mouse
Mason Hardy, Yuncai Chen, … Nicholas J. Justice·Brain Structure and FunctionPeer-reviewed·Dec 18, 2024
- Subpopulations of corticotropin-releasing factor containing neurons and internal circuits in the chicken central extended amygdala
Alessandra Pross, Alek H. Metwalli, … Loreta M. Medina·The Journal of Comparative NeurologyPeer-reviewed·Dec 17, 2023
- Corticotropin-Releasing Factor Neurons in the Bed Nucleus of the Stria Terminalis Differentially Influence Pain Processing and Modulation in Male and Female Mice
Waylin Yu, Christina M. Stanhope, … Thomas L. Kash·Scientific ReportsPeer-reviewed·Jun 14, 2021
- Chemogenetic stimulation of mouse central amygdala corticotropin-releasing factor neurons: Effects on cellular and behavioral correlates of alcoholdependence
Max Kreifeldt, Melissa A. Herman, … Candice Contet·bioRxiv·Feb 7, 2020
- Chemogenetic activation of corticotropin-releasing factor-expressing neurons in the anterior bed nucleus of the stria terminalis reduces effortful motivation behaviors
Isabella Maita, Allyson S. Bazer, … Benjamin Adam Samuels·NeuropsychopharmacologyPeer-reviewed·Jul 14, 2023
- Factors of sex and age dictate the regulation of GABAergic activity by corticotropin-releasing factor receptor 1 in the medial sub-nucleus of the central amygdala.
Siara Kate Rouzer, Marvin Rafael Diaz·NeuropharmacologyPeer-reviewed·Mar 18, 2021